The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Myocardial Revascularization

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Myocardial Revascularization


High impact information on Myocardial Revascularization


Chemical compound and disease context of Myocardial Revascularization


Biological context of Myocardial Revascularization


Anatomical context of Myocardial Revascularization


Associations of Myocardial Revascularization with chemical compounds


Gene context of Myocardial Revascularization

  • Plasma levels of procalcitonin (PCT), c-reactive protein (CRP), interleukin-6 (IL-6), and LBP were measured in the first four postoperative days in 12 adult male patients with the signs of SIRS and two or more organ dysfunctions after myocardial revascularization (MODS-group), and 12 patients without organ insufficiencies (SIRS-group) [31].
  • Four patients of the 14 patients in the high free TFPI group required myocardial revascularization during in-hospital stay, and 4 of the 37 patients in the low free TFPI group required myocardial revascularization [32].
  • The aim of this study was to assess the perioperative levels of Hcy, copper, ceruloplasmin (CP), folate, and vitamin B12 in patients undergoing myocardial revascularization surgery [33].
  • DESIGN: Since adenosine administration is a promising approach for the prevention of the ischemia-reperfusion in myocardial revascularization, the aim of this study was to investigate whether the AMPD1 (-) allele is associated with a favorable prognosis after coronary revascularization [34].
  • On the other hand, only 1 of the 29 patients in the low TF group required myocardial revascularization [32].

Analytical, diagnostic and therapeutic context of Myocardial Revascularization


  1. Potassium cardioplegia: early assessment by radionuclide ventriculography. Ellis, R.J., Born, M., Feit, T., Ebert, P.A. Circulation (1978) [Pubmed]
  2. Inhibition of the adrenocorticotropin response to surgery in humans: interaction between dexamethasone and fentanyl. Raff, H., Norton, A.J., Flemma, R.J., Findling, J.W. J. Clin. Endocrinol. Metab. (1987) [Pubmed]
  3. Isradipine for treatment of acute hypertension after myocardial revascularization. Brister, N.W., Barnette, R.E., Schartel, S.A., McClurken, J.B., Alpern, J. Crit. Care Med. (1991) [Pubmed]
  4. Urine and plasma catecholamine and cortisol concentrations after myocardial revascularization. Modulation by continuous sedation. Multicenter Study of Perioperative Ischemia (McSPI) Research Group, and the Ischemia Research and Education Foundation (IREF). Plunkett, J.J., Reeves, J.D., Ngo, L., Bellows, W., Shafer, S.L., Roach, G., Howse, J., Herskowitz, A., Mangano, D.T. Anesthesiology (1997) [Pubmed]
  5. Oral verapamil for prophylaxis of supraventricular tachycardia after myocardial revascularization. A randomized trial. Williams, D.B., Misbach, G.A., Kruse, A.P., Ivey, T.D. J. Thorac. Cardiovasc. Surg. (1985) [Pubmed]
  6. Dipyridamole-induced myocardial ischemia. Keltz, T.N., Innerfield, M., Gitler, B., Cooper, J.A. JAMA (1987) [Pubmed]
  7. Acute ischemic ventricular septal defect. Hill, J.D., Stiles, Q.R. Circulation (1989) [Pubmed]
  8. Myocardial revascularization combined with intracoronary infusion of hyperosmolar solution in the early management of postinfarction ventricular septal defect. Report of a case. Jones, E.L., Tyras, D.H., King, S.P., Logue, R.B., Hatcher, C.R. Circulation (1975) [Pubmed]
  9. Coronary revascularization rather than cardiac transplantation for chronic ischemic cardiomyopathy. Kron, I.L., Flanagan, T.L., Blackbourne, L.H., Schroeder, R.A., Nolan, S.P. Ann. Surg. (1989) [Pubmed]
  10. Efficacy of low-dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Silverman, N.A., Wright, R., Levitsky, S. Ann. Surg. (1982) [Pubmed]
  11. Comparative efficacy of the intravenous administration of linsidomine, a direct nitric oxide donor, and isosorbide dinitrate in severe unstable angina. A French multicentre study. French Group of Investigators. Delonca, J., Giraud, T., Beaufils, P., Dupuis, B., Haïat, R., Théry, C. Eur. Heart J. (1997) [Pubmed]
  12. Propranolol therapy in patients undergoing myocardial revascularization. Jones, E.L., Kaplan, J.A., Dorney, E.R., King, S.B., Douglas, J.S., Hatcher, C.R. Am. J. Cardiol. (1976) [Pubmed]
  13. Heart transplantation without informed consent: discussion of a case. Grande, A.M., Rinaldi, M., Goggi, C., Politi, P., Viganò, M. Intensive care medicine. (1998) [Pubmed]
  14. Comparison of cod-liver oil and aspirin-dipyridamole for the prevention of intimal hyperplasia in autologous vein grafts. Landymore, R.W., MacAulay, M., Sheridan, B., Cameron, C. Ann. Thorac. Surg. (1986) [Pubmed]
  15. Laser myocardial revascularization. Mirhoseini, M., Cayton, M.M., Shelgikar, S., Fisher, J.C. Lasers in surgery and medicine. (1986) [Pubmed]
  16. One-year effect of myocardial revascularization on resting left ventricular function and regional thallium uptake in chronic CAD. Cuocolo, A., Nicolai, E., Petretta, M., Morisco, C., De Luca, N., Salvatore, M., Trimarco, B. J. Nucl. Med. (1997) [Pubmed]
  17. PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease. Tio, R.A., Tan, E.S., Jessurun, G.A., Veeger, N., Jager, P.L., Slart, R.H., de Jong, R.M., Pruim, J., Hospers, G.A., Willemsen, A.T., de Jongste, M.J., van Boven, A.J., van Veldhuisen, D.J., Zijlstra, F. J. Nucl. Med. (2004) [Pubmed]
  18. Effects of propranolol on perceived exertion soon after myocardial revascularization surgery. Squires, R.W., Rod, J.L., Pollock, M.L., Foster, C. Medicine and science in sports and exercise. (1982) [Pubmed]
  19. Comparison of Ringer's acetate and lactate solutions as a prime for cardiopulmonary bypass. Takkunen, O., Salmenperä, M., Heinonen, J. Annales chirurgiae et gynaecologiae. (1985) [Pubmed]
  20. Effects of phenylephrine or volume loading on right ventricular function in patients undergoing myocardial revascularization. Tuman, K.J., McCarthy, R.J., March, R.J., Guynn, T.P., Ivankovich, A.D. J. Cardiothorac. Vasc. Anesth. (1995) [Pubmed]
  21. A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery. Huraux, C., Makita, T., Montes, F., Szlam, F., Levy, J.H. Anesthesiology (1998) [Pubmed]
  22. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. Ruel, M., Laham, R.J., Parker, J.A., Post, M.J., Ware, J.A., Simons, M., Sellke, F.W. J. Thorac. Cardiovasc. Surg. (2002) [Pubmed]
  23. Nicardipine infusion for the prevention of radial artery spasm during myocardial revascularization. Grigore, A.M., Castro, J.L., Swistel, D., Thys, D.M. J. Cardiothorac. Vasc. Anesth. (1998) [Pubmed]
  24. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. Feneck, R.O. J. Cardiothorac. Vasc. Anesth. (1992) [Pubmed]
  25. Pharmacokinetic-based total intravenous anaesthesia using remifentanil and propofol for surgical myocardial revascularization. Guarracino, F., Penzo, D., De Cosmo, D., Vardanega, A., De Stefani, R. European journal of anaesthesiology. (2003) [Pubmed]
  26. Perioperative myocardial infarction diagnosed by technetium 99m stannous pyrophosphate myocardial scintigrams. Platt, M.R., Mills, L.J., Parkey, R.W., Willerson, J.T., Bonte, F.J., Shapiro, W., Sugg, W.L. Circulation (1976) [Pubmed]
  27. Fast cortisol-induced inhibition of the adrenocorticotropin response to surgery in humans. Raff, H., Flemma, R.J., Findling, J.W. J. Clin. Endocrinol. Metab. (1988) [Pubmed]
  28. Left ventricular performance indices by transesophageal Doppler. Thys, D.M., Hillel, Z. Anesthesiology (1988) [Pubmed]
  29. Postoperative myocardial ischemia. Therapeutic trials using intensive analgesia following surgery. The Study of Perioperative Ischemia (SPI) Research Group. Mangano, D.T., Siliciano, D., Hollenberg, M., Leung, J.M., Browner, W.S., Goehner, P., Merrick, S., Verrier, E. Anesthesiology (1992) [Pubmed]
  30. Altered hemodynamic response to dobutamine in relation to the degree of preoperative beta-adrenoceptor blockade. Tarnow, J., Komar, K. Anesthesiology (1988) [Pubmed]
  31. Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery. Sablotzki, A., Börgermann, J., Baulig, W., Friedrich, I., Spillner, J., Silber, R.E., Czeslick, E. The Thoracic and cardiovascular surgeon. (2001) [Pubmed]
  32. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Soejima, H., Ogawa, H., Yasue, H., Kaikita, K., Nishiyama, K., Misumi, K., Takazoe, K., Miyao, Y., Yoshimura, M., Kugiyama, K., Nakamura, S., Tsuji, I., Kumeda, K. Circulation (1999) [Pubmed]
  33. Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting. Jeremy, J.Y., Shukla, N., Angelini, G.D., Day, A., Wan, I.Y., Talpahewa, S.P., Ascione, R. Ann. Thorac. Surg. (2002) [Pubmed]
  34. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization. Andreassi, M.G., Botto, N., Laghi-Pasini, F., Manfredi, S., Ghelarducci, B., Farneti, A., Solinas, M., Biagini, A., Picano, E. International journal of cardiology. (2005) [Pubmed]
  35. Premedication and high-dose fentanyl anesthesia for myocardial revascularization: a comparison of lorazepam versus morphine-scopolamine. Thomson, I.R., Bergstrom, R.G., Rosenbloom, M., Meatherall, R.C. Anesthesiology (1988) [Pubmed]
  36. Segmental wall motion abnormalities during telerobotic totally endoscopic coronary artery bypass grafting. Mierdl, S., Byhahn, C., Dogan, S., Aybek, T., Wimmer-Greinecker, G., Kessler, P., Meininger, D., Westphal, K. Anesth. Analg. (2002) [Pubmed]
  37. Direct CO2 laser "revascularization" of the myocardium. Landreneau, R., Nawarawong, W., Laughlin, H., Ripperger, J., Brown, O., McDaniel, W., McKown, D., Curtis, J. Lasers in surgery and medicine. (1991) [Pubmed]
  38. Myocardial preservation using lidocaine blood cardioplegia. Fiore, A.C., Naunheim, K.S., Taub, J., Braun, P., McBride, L.R., Pennington, D.G., Kaiser, G.C., Willman, V.L., Barner, H.B. Ann. Thorac. Surg. (1990) [Pubmed]
  39. Strain rate dobutamine echocardiography for prediction of recovery after revascularization in patients with ischemic left ventricular dysfunction. Vitarelli, A., Montesano, T., Gaudio, C., Conde, Y., Cimino, E., D'angeli, I., D'orazio, S., Stellato, S., Battaglia, D., Padella, V., Caranci, F., Ciancamerla, M., Di Nicola, A.D., Ronga, G. J. Card. Fail. (2006) [Pubmed]
WikiGenes - Universities